FINDSITE(X): a structure-based, small molecule virtual screening approach with application to all identified human GPCRs.
about
Modeling enzyme-ligand binding in drug discoveryPoLi: A Virtual Screening Pipeline Based on Template Pocket and Ligand Similarity.Experimental validation of FINDSITE(comb) virtual ligand screening results for eight proteins yields novel nanomolar and micromolar binders.FINDSITE(comb): a threading/structure-based, proteomic-scale virtual ligand screening approachENTPRISE: An Algorithm for Predicting Human Disease-Associated Amino Acid Substitutions from Sequence Entropy and Predicted Protein StructuresComprehensive prediction of drug-protein interactions and side effects for the human proteome.GLASS: a comprehensive database for experimentally validated GPCR-ligand associationsBioLiP: a semi-manually curated database for biologically relevant ligand-protein interactionsAre predicted protein structures of any value for binding site prediction and virtual ligand screening?Repurposing FDA-approved drugs for anti-aging therapies.Novel small molecule binders of human N-glycanase 1, a key player in the endoplasmic reticulum associated degradation pathway.Improvements, trends, and new ideas in molecular docking: 2012-2013 in review.Expanding the horizons of G protein-coupled receptor structure-based ligand discovery and optimization using homology models.Pocket detection and interaction-weighted ligand-similarity search yields novel high-affinity binders for Myocilin-OLF, a protein implicated in glaucoma.On the origins of drug polypharmacologySPOT-Ligand: Fast and effective structure-based virtual screening by binding homology search according to ligand and receptor similarity
P2860
Q26784325-B402FCBB-A972-4D6E-B167-6494083A62E3Q30377334-06D26723-9C98-499A-9B42-AAC788E45BB9Q33685192-042AAB0B-8DAD-43A0-9117-9E767A577FEAQ34512813-19BE8097-7F48-475A-AB1A-C34B80BD2C81Q35959723-CB4F2E24-F137-45B4-92E3-726C67419C3AQ36156312-99D88E12-ABF8-491D-8E32-B829A90AC817Q36344531-E635B6A3-6B4B-4208-AB47-2B5CCF79FACFQ36491539-67C9EFC2-876E-4B4E-BE9D-85C4B5C9B7E6Q36859642-EF0CAA35-1BBB-485A-B73A-91ACC31CDAD4Q37341939-76CF60B7-46BF-491E-98FF-F4FA1BE1A99BQ38291144-B94C5B27-1099-4B0F-ADC6-29EE932343C5Q38390892-6E2DF6A2-3AB1-4C64-9CCB-C0DCB27171CFQ38976083-94E4CAF3-3289-4D34-85C6-E1D0205CE42CQ50873769-4DC1F504-5679-4D17-B14B-B73F61989706Q57012617-1DFCD43F-614F-49EF-9063-B8BF618469F1Q58041489-6064773C-E6D2-4ADC-AB6D-6745EBF80F0B
P2860
FINDSITE(X): a structure-based, small molecule virtual screening approach with application to all identified human GPCRs.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
FINDSITE(X): a structure-based ...... to all identified human GPCRs.
@ast
FINDSITE(X): a structure-based ...... to all identified human GPCRs.
@en
FINDSITE(X): a structure-based ...... to all identified human GPCRs.
@nl
type
label
FINDSITE(X): a structure-based ...... to all identified human GPCRs.
@ast
FINDSITE(X): a structure-based ...... to all identified human GPCRs.
@en
FINDSITE(X): a structure-based ...... to all identified human GPCRs.
@nl
prefLabel
FINDSITE(X): a structure-based ...... to all identified human GPCRs.
@ast
FINDSITE(X): a structure-based ...... to all identified human GPCRs.
@en
FINDSITE(X): a structure-based ...... to all identified human GPCRs.
@nl
P2860
P356
P1476
FINDSITE(X): a structure-based ...... to all identified human GPCRs.
@en
P2093
Hongyi Zhou
P2860
P304
P356
10.1021/MP3000716
P407
P577
2012-05-21T00:00:00Z